Nov 12, 2019 / 01:45PM GMT
Vincent Stephen Andrews - Morgan Stanley, Research Division - MD
Well, good morning. Thank you, everyone, for coming here. I think this is our eighth or ninth Annual Chemicals Conference up here in Boston, as I've been saying to our guest today, Jim Collins, from Corteva. We've had Jim here over the years in many different forms from DuPont -- from Dow DuPont and now as first time as Corteva. So thrilled to have you here. We also have Greg Friedman and Megan Britt in the front. And I think Jim just wanted to make some prepared remarks and then we'll go into Q&A.
James C. Collins - Corteva, Inc. - CEO & Director
Okay. Sounds great. Good morning, everyone, and thanks, Vincent. It is a pleasure to be back here. And as you said, many different faces over the years, but certainly always excited to spend a little time. We look forward to not only today here but also in some one-on-ones, continuing to update everybody on kind of those key priorities that we've set for driving shareholder value creation as we launch and really develop this great company, Corteva.
Corteva Inc at Morgan Stanley Global Chemicals and Agriculture Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot